Cart
sales@molnova.com
AM251
CAS No. 183232-66-8
AM251 ( AM251; AM 251; AM-251 )
Catalog No. M12824 CAS No. 183232-66-8
AM251 is a potent CB1 receptor antagonist (IC50 = 8 nM, Ki = 7.49 nM) that displays 306-fold selectivity over CB2 receptors; also potent GPR55 agonist (EC50 = 39 nM).
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 39 | In Stock |
|
| 10MG | 65 | In Stock |
|
| 25MG | 119 | In Stock |
|
| 50MG | 212 | In Stock |
|
| 100MG | 313 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAM251
-
NoteResearch use only, not for human use.
-
Brief DescriptionAM251 is a potent CB1 receptor antagonist (IC50 = 8 nM, Ki = 7.49 nM) that displays 306-fold selectivity over CB2 receptors; also potent GPR55 agonist (EC50 = 39 nM).
-
DescriptionAM251 is a potent CB1 receptor antagonist (IC50 = 8 nM, Ki = 7.49 nM) that displays 306-fold selectivity over CB2 receptors; also potent GPR55 agonist (EC50 = 39 nM).
-
SynonymsAM251; AM 251; AM-251
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCB1
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number183232-66-8
-
Formula Weight555.24
-
Molecular FormulaC22H21Cl2IN4O
-
Purity>98%(HPLC)
-
SolubilityDMSO: 40 mg/mL (72.04 mM)
-
SMILESO=C(C1=NN(C2=CC=C(Cl)C=C2Cl)C(C3=CC=C(I)C=C3)=C1C)NN4CCCCC4
-
Chemical Name1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Thewke D, et al. Biochem Biophys Res Commun, 2009, 381(2), 181-186.
molnova catalog
related products
-
Repertaxin
Reparixin is a potent inhibitor of both CXCL8 receptorsCXCR1/2, it inhibits weaklyCXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocksCXCR1-mediated chemotaxis (IC50=1 nM).
-
AM-2201
A synthetic cannabinoid that acts as a potent, nonselective full agonist for the cannabinoid receptor with EC50 of 38 and 58 nM for CB1 and CB2, respectively.
-
A 834735
A potent, nonselective, brain penetrant, full agonist at both the central CB1 and peripheral CB2 receptors with Ki of 4.6 and 0.31 nM, respectively.
